Skip to main content
Seegnal logo

Seegnal — Investor Relations & Filings

Ticker · SEGN ISIN · CA81573E1060 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 102 across all filing types
Latest filing 2025-07-31 Regulatory Filings
Country CA Canada
Listing TSXV SEGN

About Seegnal

https://www.seegnal.com/

Seegnal is a healthcare technology provider specializing in SaaS clinical decision support solutions, marketed as the enterprise Prescription Operating System (Prescription OS). The platform's core function is to mitigate Adverse Drug Effects (ADEs) and reduce patient risk by enabling precision prescribing. Seegnal continuously analyzes prescribing decisions in real-time, leveraging comprehensive clinical context, including patient medications, diagnoses, and lab results. This system delivers measurable clinical ROI and significantly reduces alert fatigue, reportedly lowering alert load by up to 94%. Key modules, such as Seegnal Guard and MetricsGuard, provide real-time, explainable alerts, empowering clinicians while ensuring that all final prescribing decisions remain fully under their control.

Recent filings

Filing Released Lang Actions
Decision Document (Final).pdf
Regulatory Filings Classification · 0% confidence The document is a short notice from the Alberta Securities Commission acknowledging receipt of a Long Form Prospectus filed under various securities instruments and passport systems. It is not the prospectus itself but a regulatory receipt/acknowledgment. There is no content of a financial report, board change, or dividend, nor is it a management discussion or earnings release. It falls under miscellaneous regulatory announcements that do not fit other specific categories. Therefore, it is best classified as a general Regulatory Filing (RNS).
2025-07-31 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 certification by the CFO under Canadian securities rules, certifying interim financial statements and MD&A. It is not the interim report itself (IR) but a regulatory certificate filing. There is no specific category for certification forms, so it falls under the fallback Regulatory Filings category (RNS).
2025-07-31 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 Venture Issuer Basic Certificate certifying the issuer’s interim financial report and interim MD&A. It is not the interim report itself nor an announcement of report publication, but a required regulatory certification filing under NI 52-109. It does not match any more specific category and thus falls into the general Regulatory Filings category.
2025-07-31 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is a Management’s Discussion and Analysis (MD&A) for the three and nine months ended May 31, 2025, which provides management’s detailed explanation of financial performance, business trends, and outlook for an interim period. This matches the definition of Management Reports (Code: MDA) rather than an actual interim financial report or earnings release.
2025-07-31 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Unaudited Interim Condensed Financial Statements' for Reem Capital Corp. for the three and nine months ended May 31, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Shareholders' Equity, and Statement of Cash Flows) along with detailed notes to the financial statements. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q2 2025
2025-07-31 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings Classification · 1% confidence The document is an appendix to National Instrument 41-101 – a non-issuer form of submission to jurisdiction and appointment of agent for service of process related to a securities prospectus. It is a regulatory compliance filing rather than a financial report, management announcement, or transaction notice. There is no specific category for prospectus forms, so it falls under the fallback category “Regulatory Filings (RNS).”
2025-07-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.